Medicine /Simmons NURP 502 Exam 1 3: Asthma Classification
Intermittent, mild persistent, moderate persistent, or severe persistent? Requires SABA >2 days/week but not >1/day.
Mild Persistent
Tap or swipe ↕ to flip
Swipe ←→Navigate
SSpeak
FFocus
1/31
Key Terms
Term
Definition
Intermittent, mild persistent, moderate persistent, or severe persistent? Requires SABA >2 days/week but not >1/day.
Mild Persistent
What treatment step is appropriate for intermittent in all ages?
Step 1: SABA PRN
Intermittent, mild persistent, moderate persistent, or severe persistent? Extremely limited physical activity.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent? Requires SABA several times/day.
Severe Persistent
Intermittent, mild persistent, moderate persistent, or severe persistent? Nighttime symptoms often 7 times per week (5+ age group). Nighttime symptoms >1 times per week (0-4 age group).
Severe Persistent
What treatment step is appropriate for mild persistent in all ages?
Step 2: Low-dose ICS
Related Flashcard Decks
Study Tips
- Press F to enter focus mode for distraction-free studying
- Review cards regularly to improve retention
- Try to recall the answer before flipping the card
- Share this deck with friends to study together
Term | Definition |
---|---|
Intermittent, mild persistent, moderate persistent, or severe persistent? Requires SABA >2 days/week but not >1/day. | Mild Persistent |
What treatment step is appropriate for intermittent in all ages? | Step 1: SABA PRN |
Intermittent, mild persistent, moderate persistent, or severe persistent? Extremely limited physical activity. | Severe Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Requires SABA several times/day. | Severe Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Nighttime symptoms often 7 times per week (5+ age group). Nighttime symptoms >1 times per week (0-4 age group). | Severe Persistent |
What treatment step is appropriate for mild persistent in all ages? | Step 2: Low-dose ICS |
Intermittent, mild persistent, moderate persistent, or severe persistent? Nighttime symptoms 3-4 times per month (5+ age group). Nighttime symptoms 1-2 times per month (0-4 age group). | Mild Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Exacerbations are 0-1/year. | Intermittent |
Intermittent, mild persistent, moderate persistent, or severe persistent? FEV1 >80% predicted. | • Intermittent • Mild Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Symptoms >2 times per week but <1 time per day. | Mild Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Daily use of inhaled SABA. | Moderate Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Exacerbations affect activity, ≥2 times per week; may last days. | Moderate Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? FEV1 <60% predicted. | Severe Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Asymptomatic and normal PEF between exacerbations. | Intermittent |
What treatment step is appropriate for severe persistent in ages 0-4, 5-11, and 12+? | • Step 3: Medium-dose ICS and consider short-course OCS (0-11 only). • Step 4: Medium-dose ICS + LABA and consider short-course OCS (5+ only). • Step 5: High-dose ICS + LABA and consider short-course OCS (12+ only). |
Intermittent, mild persistent, moderate persistent, or severe persistent? Symptoms ≤2 times per week. | Intermittent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Requires SABA 2 days/week. | Intermittent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Exacerbations brief (few hours or days); varying intensity. | Intermittent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Daily symptoms. | Moderate Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Continual symptoms. | Severe Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Some limitations to daily activities. | Moderate Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? All are started on long-term control medications. | Severe persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? FEV1 >60% but <80% predicted. | Moderate Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Normal FEV1 between exacerbations. | Intermittent |
What treatment step is appropriate for moderate persistent in 0-11 years and 12+? | Step 3: Medium-dose ICS and consider short-course OCS (all ages) Step 3: Low-dose ICS + LABA (12+ only). |
Intermittent, mild persistent, moderate persistent, or severe persistent? No interference with normal activity. | Intermittent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Exacerbations may affect activity (minor). | Mild Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Nighttime symptoms ≤2 times per month (5+ age group). Nighttime symptoms 0 times per month (0-4 age group). | Intermittent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Frequent exacerbations. | Severe Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Nighttime symptoms >1 time per week but not nightly (5+ age group). Nighttime symptoms 3-4 times per month (0-4 age group). | Moderate Persistent |
Intermittent, mild persistent, moderate persistent, or severe persistent? Exacerbations are 2 or more/6 months or ≥4 episodes of wheezing/year with risk factors for asthma (0-4 age group). Exacerbations are 2 or more/year (5+ age group). | Mild Persistent (all ages) Moderate Persistent (5+ age group) Severe Persistent (5+ age group) |